BlackRock, Inc. 13D and 13G filings for CorMedix Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | CorMedix Inc. CRMD |
BlackRock Inc. BLK |
4,567,897 7.500% |
1,060,202![]() (+30.23%) |
Filing |
2024-01-29 3:26 pm Purchase |
2023-12-31 | 13G | CorMedix Inc. CRMD |
BlackRock Inc. BLK |
3,507,695 6.400% |
2,869,917![]() (+449.99%) |
Filing |
2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | CorMedix Inc. CRMD |
BlackRock Inc. BLK |
637,778 1.600% |
-1,862,943![]() (-74.50%) |
Filing |
2022-02-02 7:18 pm Purchase |
2021-12-31 | 13G | CorMedix Inc. CRMD |
BlackRock Inc. BLK |
2,500,721 6.600% |
505,528![]() (+25.34%) |
Filing |
2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | CorMedix Inc. CRMD |
BlackRock Inc. BLK |
1,995,193 6.200% |
282,292![]() (+16.48%) |
Filing |